Muller MP - Search Results

1

Identification of prosthetic hip and knee joint infections using administrative databases-A validation study.

Kandel CE, Jenkinson R, Widdifield J, Hansen BE, Davey JR, Muller MP, Daneman N, McGeer A. Kandel CE, et al. Among authors: muller mp. Infect Control Hosp Epidemiol. 2021 Mar;42(3):325-330. doi: 10.1017/ice.2020.449. Epub 2020 Sep 30. Infect Control Hosp Epidemiol. 2021. PMID: 32993826

2

Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance.

Low DE, Muller M, Duncan CL, Willey BM, de Azavedo JC, McGeer A, Kreiswirth BN, Pong-Porter S, Bast DJ. Low DE, et al. Antimicrob Agents Chemother. 2002 Apr;46(4):1119-21. doi: 10.1128/AAC.46.4.1119-1121.2002. Antimicrob Agents Chemother. 2002. PMID: 11897603 Free PMC article.

3

Variation in approach to ESBL Enterobacteriaceae among infection control practitioners: results of an Ontario-wide survey.

Muller M, McGeer A. Muller M, et al. Can Commun Dis Rep. 2002 Aug 1;28(15):121-4. Can Commun Dis Rep. 2002. PMID: 12168403 English, French. No abstract available.

4

Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada.

Muller MP, Low DE, Green KA, Simor AE, Loeb M, Gregson D, McGeer A; Ontario Group A Streptococcal Study. Muller MP, et al. Arch Intern Med. 2003 Feb 24;163(4):467-72. doi: 10.1001/archinte.163.4.467. Arch Intern Med. 2003. PMID: 12588207

5

Clinical trials and novel pathogens: lessons learned from SARS.

Muller MP, McGeer A, Straus SE, Hawryluck L, Gold WL. Muller MP, et al. Emerg Infect Dis. 2004 Mar;10(3):389-94. doi: 10.3201/eid1003.030702. Emerg Infect Dis. 2004. PMID: 15109402 Free PMC article.

6

Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?

Muller MP, Tomlinson G, Marrie TJ, Tang P, McGeer A, Low DE, Detsky AS, Gold WL. Muller MP, et al. Clin Infect Dis. 2005 Apr 15;40(8):1079-86. doi: 10.1086/428577. Epub 2005 Mar 16. Clin Infect Dis. 2005. PMID: 15791504 Free PMC article.

7

Febrile respiratory illness in the intensive care unit setting: an infection control perspective.

Muller MP, McGeer A. Muller MP, et al. Curr Opin Crit Care. 2006 Feb;12(1):37-42. doi: 10.1097/01.ccx.0000198056.58083.a1. Curr Opin Crit Care. 2006. PMID: 16394782 Review.

8

Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.

Muller MP, Dresser L, Raboud J, McGeer A, Rea E, Richardson SE, Mazzulli T, Loeb M, Louie M; Canadian SARS Research Network. Muller MP, et al. Pharmacotherapy. 2007 Apr;27(4):494-503. doi: 10.1592/phco.27.4.494. Pharmacotherapy. 2007. PMID: 17381375 Free PMC article.

9

Severe acute respiratory syndrome (SARS) coronavirus.

Muller MP, McGeer A. Muller MP, et al. Semin Respir Crit Care Med. 2007 Apr;28(2):201-12. doi: 10.1055/s-2007-976492. Semin Respir Crit Care Med. 2007. PMID: 17458774

10

Impact of a mandatory infection control education program on nosocomial acquisition of methicillin-resistant Staphylococcus aureus.

Lee TC, Moore C, Raboud JM, Muller MP, Green K, Tong A, Dhaliwal J, McGeer A; Mount Sinai Hospital Infection Control Team. Lee TC, et al. Among authors: muller mp. Infect Control Hosp Epidemiol. 2009 Mar;30(3):249-56. doi: 10.1086/596042. Infect Control Hosp Epidemiol. 2009. PMID: 19199825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters